- Home
- ABBV vs TTE Comparison
ABBV vs TTE Comparison
Compare ABBV & TTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | TTE |
|---|---|---|
| Founded | 2012 | 1924 |
| Country | United States | France |
| Employees | N/A | 101513 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.5B | 205.5B |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABBV | TTE |
|---|---|---|
| Price | $247.71 | $76.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 8 |
| Target Price | ★ $253.71 | $76.63 |
| AVG Volume (30 Days) | ★ 4.1M | 1.4M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | 3.39% | ★ 4.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $61,160,000,000.00 | N/A |
| Revenue This Year | $11.87 | $28.83 |
| Revenue Next Year | $8.12 | N/A |
| P/E Ratio | $625.28 | ★ $12.60 |
| Revenue Growth | ★ 8.57 | N/A |
| 52 Week Low | $181.75 | $57.40 |
| 52 Week High | $244.81 | $94.17 |
Technical Indicators
Market Signals| Indicator | ABBV | TTE |
|---|---|---|
| Relative Strength Index (RSI) | 75.20 | 19.05 |
| Support Level | $213.65 | $76.56 |
| Resistance Level | N/A | $93.66 |
| Average True Range (ATR) | 5.90 | 1.51 |
| MACD | 2.32 | -0.93 |
| Stochastic Oscillator | 99.62 | 0.99 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About TTE TotalEnergies SE
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2025, it produced 1.5 million barrels of liquids and 5.4 billion cubic feet of natural gas per day. At the end of 2025, reserves stood at 11.2 billion barrels of oil equivalent, 55% of which are liquids. During 2025, it had LNG sales of 43.9 million metric tons. The company owns interests in refineries with a capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 34 gigawatts.